Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015098 |
---|---|
Receipt number | R000017566 |
Scientific Title | Phase II study of S-1+CPT-11+Bevacizumab as second-line therapy in metastatic colorectal cancer which has prior therapy of S-1+L-OHP+Bevacizumab |
Date of disclosure of the study information | 2014/09/09 |
Last modified on | 2019/10/07 14:49:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/09 16:13:52 | ||
2 | Update | 2014/09/09 16:30:53 | Date of disclosure of the study information |
|
3 | Update | 2019/09/30 17:53:56 | UMIN ID1 |
|
4 | Update | 2019/10/07 14:49:57 | Recruitment status Date of IRB Last follow-up date |